InsiderTrades

Form 4 for INGN Inogen Inc

Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-01 · accession 0000950170-24-053100 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-03 2024-05-01 INGN Glezer Stanislav EVP, R, D, Chief Med. Off M - OptEx $0.00 +32.6K 48.7K +203% $0
D 2024-05-03 2024-05-01 INGN Glezer Stanislav EVP, R, D, Chief Med. Off F - Tax $7.05 -16.7K 32.0K -34% -$117.7K
D 2024-05-03 2024-05-01 INGN Glezer Stanislav EVP, R, D, Chief Med. Off M - OptEx $0.00 -32.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-01 M A 32,638 $0.00 48,744 D — —
2 Common Common Stock 2024-05-01 F D 16,695 $7.05 32,049 D — — (F1) The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on May 1, 2024.
3 Derivative Restricted Stock Unit 2024-05-01 M D 32,638 $0.00 0 D — · — to — 32,638 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. (F3) Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024